Logo

Ambion to Supply Wyeth with RNA

Oct 04, 2002

SAN FRANCISCO, Oct. 4 - Ambion's diagnostic division will develop and manufacture RNA for Wyeth, the company said today.

 

Austin, Texas-based Ambion RNA Diagnostics will optimize processes for synthesizing long RNA molecules and translation into protein, and manufacture the cGMP-grade RNA transcripts for Wyeth's use in its vaccine program, the company said.

 

Financial details of the agreement were not disclosed.

 

Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.